369 related articles for article (PubMed ID: 22359151)
21. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
Berman B; Seeberger L; Kumar R
Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cervical dystonia with botulinum toxin.
Jankovic J
Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
[TBL] [Abstract][Full Text] [Related]
24. Treatment of cervical dystonia with botulinum toxins.
Comella CL; Thompson PD
Eur J Neurol; 2006 Feb; 13 Suppl 1():16-20. PubMed ID: 16417593
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin Therapy for Parkinson's Disease.
Wagle Shukla A; Malaty IA
Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
[TBL] [Abstract][Full Text] [Related]
27. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Ford B; Louis ED; Greene P; Fahn S
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
[TBL] [Abstract][Full Text] [Related]
28. "Pseudo"-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study.
Hefter H; Rosenthal D; Samadzadeh S
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888649
[TBL] [Abstract][Full Text] [Related]
29. [Botulinum toxin therapy for focal dystonia].
Hahn K; Niklai E; Garzuly F; Szupera Z
Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
[TBL] [Abstract][Full Text] [Related]
30. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
31. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
[TBL] [Abstract][Full Text] [Related]
32. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
[TBL] [Abstract][Full Text] [Related]
33. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
Truong DD; Bhidayasiri R
Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
[TBL] [Abstract][Full Text] [Related]
35. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
Marciniec M; Szczepańska-Szerej A; Rejdak K
Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
[TBL] [Abstract][Full Text] [Related]
36. Xeomin in the treatment of cervical dystonia.
Benecke R
Eur J Neurol; 2009 Dec; 16 Suppl 2():6-10. PubMed ID: 20002740
[TBL] [Abstract][Full Text] [Related]
37. Self-reported benefit and weakness after botulinum toxin in dystonia.
Kassavetis P; Lungu C; Ehrlich D; Alter K; Karp BI
Parkinsonism Relat Disord; 2020 Nov; 80():10-11. PubMed ID: 32927341
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
Marsili L; Bologna M; Jankovic J; Colosimo C
Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
[No Abstract] [Full Text] [Related]
39. Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy-A Narrative Review of the Literature.
Odorfer TM; Volkmann J
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888637
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type F for treatment of dystonia: long-term experience.
Chen R; Karp BI; Hallett M
Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
